{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:43:04Z","timestamp":1792600984037,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004332","name":"Seoul National University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004332","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["04-2025-0350"],"award-info":[{"award-number":["04-2025-0350"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2024-00359653"],"award-info":[{"award-number":["RS-2024-00359653"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2024-00512914"],"award-info":[{"award-number":["RS-2024-00512914"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119635","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:24:15Z","timestamp":1782199455000},"page":"119635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["GLP-1 receptor agonist-induced transient retinal perfusion delay and its potential mediation by intracranial pressure"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6476-0135","authenticated-orcid":false,"given":"Yun Kyung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan Yi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Na","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Joong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3500-2984","authenticated-orcid":false,"given":"Hyun Beom","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119635_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102782","article-title":"GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review","volume":"75","author":"Alfaris","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.biopha.2026.119635_bib2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.clinthera.2018.11.013","article-title":"Effects of acute GLP-1 infusion on pulmonary and systemic hemodynamics in patients with heart failure: a pilot study","volume":"41","author":"Clarke","year":"2019","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119635_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-55724-z","article-title":"The impact of GLP-1 receptor agonist liraglutide on blood pressure profile, hydration, natriuresis in diabetic patients with severely impaired kidney function","volume":"14","author":"Wajdlich","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119635_bib4","article-title":"GLP-1 receptor agonists and pulmonary hypertension in diabetes: a promising therapeutic strategy","volume":"55","author":"Albulushi","year":"2025","journal-title":"Am. Heart J."},{"issue":"3","key":"10.1016\/j.biopha.2026.119635_bib5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/dom.13538","article-title":"Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: a review","volume":"21","author":"Bain","year":"2019","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2026.119635_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40942-024-00620-x","article-title":"Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes","volume":"10","author":"Grauslund","year":"2024","journal-title":"Int. J. Retin. Vitr."},{"key":"10.1016\/j.biopha.2026.119635_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2024.2296","article-title":"Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide","author":"Hathaway","year":"2024","journal-title":"JAMA Ophthalmol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119635_bib8","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1111\/dom.16316","article-title":"Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: a Danish-Norwegian cohort study","volume":"27","author":"Simonsen","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.biopha.2026.119635_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2024.6555","article-title":"Semaglutide and nonarteritic anterior ischemic optic neuropathy","author":"Cai","year":"2025","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.biopha.2026.119635_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2025.0005","article-title":"Semaglutide and risk of NAION-additional insights","author":"Rizzo","year":"2025","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.biopha.2026.119635_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2026.04.008","article-title":"Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Consensus Statement by the North American Neuro-Ophthalmology Society and the American Academy of Ophthalmology","author":"DeParis","year":"2026","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.biopha.2026.119635_bib12","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1001\/jamaophthalmol.2025.0349","article-title":"Semaglutide and nonarteritic anterior ischemic optic neuropathy risk among patients with diabetes","volume":"143","author":"Hsu","year":"2025","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.biopha.2026.119635_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2025.2332","article-title":"GLP-1RA exposure and nonarteritic anterior ischemic optic neuropathy prevalence by diabetes status","author":"Nagdeve","year":"2025","journal-title":"JAMA Ophthalmol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119635_bib14","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.1471-4159.1996.66030920.x","article-title":"Expression of the glucagon-like peptide-1 receptor gene in rat brain","volume":"66","author":"Alvarez","year":"1996","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.biopha.2026.119635_bib15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.molmet.2015.07.008","article-title":"Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain","volume":"4","author":"Cork","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.biopha.2026.119635_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2045-8118-8-10","article-title":"Transcriptome signature of the adult mouse choroid plexus","volume":"8","author":"Marques","year":"2011","journal-title":"Fluids Barriers CNS"},{"issue":"404","key":"10.1016\/j.biopha.2026.119635_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0972","article-title":"A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus","volume":"9","author":"Botfield","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.biopha.2026.119635_bib18","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/brain\/awad003","article-title":"The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial","volume":"146","author":"Mitchell","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.biopha.2026.119635_bib19","doi-asserted-by":"crossref","first-page":"44985","DOI":"10.1038\/srep44985","article-title":"Anti-inflammatory properties of shikonin contribute to improved early-stage diabetic retinopathy","volume":"7","author":"Liao","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2026.119635_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10633-006-9038-5","article-title":"Hypobaric hypoxia reduces the amplitude of oscillatory potentials in the human ERG","volume":"114","author":"Janaky","year":"2007","journal-title":"Doc. Ophthalmol."},{"issue":"404","key":"10.1016\/j.biopha.2026.119635_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0972","article-title":"A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus","volume":"9","author":"Botfield","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.biopha.2026.119635_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/03331024221147494","article-title":"Retinal vessel dynamics analysis as a surrogate marker for raised intracranial pressure in patients with suspected idiopathic intracranial hypertension","volume":"43","author":"Hagen","year":"2023","journal-title":"Cephalalgia"},{"issue":"5","key":"10.1016\/j.biopha.2026.119635_bib23","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1167\/iovs.15-16465","article-title":"Photographic reading center of the idiopathic intracranial hypertension treatment trial (IIHTT): methods and baseline results","volume":"56","author":"Fischer","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2026.119635_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dom.12651","article-title":"Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial","volume":"18","author":"Skov","year":"2016","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2026.119635_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1530\/EJE-16-0507","article-title":"Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial","volume":"176","author":"Smits","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"8","key":"10.1016\/j.biopha.2026.119635_bib26","doi-asserted-by":"crossref","first-page":"E641","DOI":"10.1152\/ajpendo.00429.2014","article-title":"Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men","volume":"308","author":"Asmar","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2026.119635_bib27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2125.2012.04214.x","article-title":"Investigation of the haemodynamic effects of exenatide in healthy male subjects","volume":"74","author":"Mendis","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119635_bib28","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13102","article-title":"Acute effects of glucagon-like peptide-1, GLP-1(9-36 amide), and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers","volume":"5","author":"Bremholm","year":"2017","journal-title":"Physiol. Rep."},{"issue":"4","key":"10.1016\/j.biopha.2026.119635_bib29","doi-asserted-by":"crossref","first-page":"E664","DOI":"10.1210\/jc.2012-3855","article-title":"Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men","volume":"98","author":"Skov","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.biopha.2026.119635_bib30","doi-asserted-by":"crossref","first-page":"E744","DOI":"10.1152\/ajpendo.00518.2015","article-title":"Glucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathy","volume":"310","author":"Asmar","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2026.119635_bib31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.114.03062","article-title":"Effects of the once-weekly glucagon-like peptide-1 receptor agonist dulaglutide on ambulatory blood pressure and heart rate in patients with type 2 diabetes mellitus","volume":"64","author":"Ferdinand","year":"2014","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.biopha.2026.119635_bib32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nm.3128","article-title":"GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure","volume":"19","author":"Kim","year":"2013","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119635_bib33","doi-asserted-by":"crossref","first-page":"F963","DOI":"10.1152\/ajprenal.00259.2012","article-title":"Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice","volume":"303","author":"Rieg","year":"2012","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2026.119635_bib34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/HYPERTENSIONAHA.120.14868","article-title":"Endogenous activation of glucagon-like peptide-1 receptor contributes to blood pressure control: role of proximal tubule Na(+)\/H(+) exchanger isoform 3, renal angiotensin II, and insulin sensitivity","volume":"76","author":"Martins","year":"2020","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.biopha.2026.119635_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00395-021-00873-9","article-title":"Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke","volume":"116","author":"Nizari","year":"2021","journal-title":"Basic Res. Cardiol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119635_bib36","doi-asserted-by":"crossref","first-page":"H2376","DOI":"10.1152\/ajpheart.00614.2005","article-title":"cAMP signal transduction induces eNOS activation by promoting PKB phosphorylation","volume":"290","author":"Zhang","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119635_bib37","doi-asserted-by":"crossref","first-page":"E1289","DOI":"10.1152\/ajpendo.00373.2007","article-title":"Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride","volume":"293","author":"Basu","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2026.119635_bib38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12886-022-02413-y","article-title":"Glucagon-like peptide-1 receptor agonist, liraglutide, attenuated retinal thickening in spontaneously diabetic Torii fatty rats","volume":"22","author":"Inoue","year":"2022","journal-title":"BMC Ophthalmol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119635_bib39","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/dom.13339","article-title":"Glucagon-like peptide-1 receptor expression in the human eye","volume":"20","author":"Hebsgaard","year":"2018","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2026.119635_bib40","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db15-0443","article-title":"Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes","volume":"65","author":"Hernandez","year":"2016","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.biopha.2026.119635_bib41","doi-asserted-by":"crossref","first-page":"H1214","DOI":"10.1152\/ajpheart.00316.2016","article-title":"GLP-1 inhibits VEGFA-mediated signaling in isolated human endothelial cells and VEGFA-induced dilation of rat mesenteric arteries","volume":"311","author":"Egholm","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"15","key":"10.1016\/j.biopha.2026.119635_bib42","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1111\/bph.15059","article-title":"Exendin-4, a GLP-1 receptor agonist regulates retinal capillary tone and restores microvascular patency after ischaemia-reperfusion injury","volume":"177","author":"Zhai","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2026.119635_bib43","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/j.apsb.2024.03.011","article-title":"Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling","volume":"14","author":"He","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biopha.2026.119635_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111976","article-title":"HIF-1alpha accumulation in response to transient hypoglycemia may worsen diabetic eye disease","volume":"42","author":"Guo","year":"2023","journal-title":"Cell. Rep."},{"issue":"36","key":"10.1016\/j.biopha.2026.119635_bib45","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1217091110","article-title":"Hypoxic retinal M\u00fcller cells promote vascular permeability by HIF-1\u2013dependent up-regulation of angiopoietin-like 4","volume":"110","author":"Xin","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2026.119635_bib46","article-title":"Hypoxia inducible factor-la is increased in ischemic retina: temporal and spatial correlation with VEGF expression","author":"Hiroaki Ozaki","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2026.119635_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1618079","article-title":"Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact","volume":"16","author":"Xie","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"20","key":"10.1016\/j.biopha.2026.119635_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012428","article-title":"Anti-inflammatory effects of GLP-1R activation in the retina","volume":"23","author":"Puddu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119635_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1167\/iovs.66.5.15","article-title":"Glucagon-like peptide 1 receptor agonist stimulation inhibits laser-induced choroidal neovascularization by suppressing intraocular inflammation","volume":"66","author":"Machida","year":"2025","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"404","key":"10.1016\/j.biopha.2026.119635_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0972","article-title":"A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus","volume":"9","author":"Botfield","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.biopha.2026.119635_bib51","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jamaneurol.2025.2020","article-title":"GLP-1 receptor agonists in idiopathic intracranial hypertension","volume":"82","author":"Sioutas","year":"2025","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119635_bib52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/archopht.1973.01000040054013","article-title":"Intracranial pressure and ocular hemodynamics","volume":"89","author":"Rios-Montenegro","year":"1973","journal-title":"Arch. Ophthalmol."},{"issue":"4","key":"10.1016\/j.biopha.2026.119635_bib53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/bjo.44.4.193","article-title":"The central artery of the retina. I. Origin and course","volume":"44","author":"Singh","year":"1960","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2026.119635_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211069744","article-title":"Ultrasonographic optic nerve sheath diameter as a noninvasive marker for intracranial hypotension","volume":"15","author":"Wang","year":"2022","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"23","key":"10.1016\/j.biopha.2026.119635_bib55","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1056\/NEJMra2101561","article-title":"Spontaneous intracranial hypotension","volume":"385","author":"Schievink","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2026.119635_bib56","doi-asserted-by":"crossref","DOI":"10.3171\/FOC-07\/11\/E8","article-title":"A review of ocular manifestations in intracranial hypotension","volume":"23","author":"Zada","year":"2007","journal-title":"Neurosurg. Focus"},{"issue":"1","key":"10.1016\/j.biopha.2026.119635_bib57","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00415-025-13560-9","article-title":"Impact of GLP-1 receptor agonists on cranial nerve palsies in type 2 diabetes: a retrospective cohort study","volume":"273","author":"Bhatia","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.biopha.2026.119635_bib58","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2025.2299","article-title":"GLP-1 RAs and risk of nonarteritic anterior ischemic optic neuropathy in older patients with diabetes","author":"Fung","year":"2025","journal-title":"JAMA Ophthalmol."},{"issue":"19","key":"10.1016\/j.biopha.2026.119635_bib59","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.119635_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13300-021-01190-z","article-title":"Early worsening of retinopathy in type 1 and type 2 diabetes after rapid improvement in glycaemic control: a systematic review","volume":"13","author":"Akil","year":"2022","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.biopha.2026.119635_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118409","article-title":"Semaglutide ameliorates retinal vascular permeability destruction in diabetic retinopathy by AnxA2-mediated MMP-9 activation and basement membrane remodeling","volume":"190","author":"Xu","year":"2025","journal-title":"Biomed. Pharmacother."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226006712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:36:53Z","timestamp":1785875813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226006712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":61,"alternative-id":["S0753332226006712"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119635","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonist-induced transient retinal perfusion delay and its potential mediation by intracranial pressure","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119635","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119635"}}